Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 187
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06470685 | Prophylactic Prostatectomy for Prostate Cancer (PPPC) | ||
| NCT02503917 | Gynaecologic Organ Segmentation and Motion Tracking Using Ultrasound | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT03946202 | KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer | ||
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT07002320 | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | ||
| NCT04359420 | What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol | ||
| NCT02447549 | Study of Tumour Focused Radiotherapy for Bladder Cancer | ||
| NCT03506997 | Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer | ||
| NCT02388230 | Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques | ||
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer | ||
| NCT02305654 | International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) | ||
| NCT03795272 | Rucaparib Maintenance Therapy in Advanced Cervical Cancer | ||
| NCT00079248 | Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer | ||
| NCT02389842 | PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib | ||
| NCT02193633 | A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel. | ||
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | ||
| NCT02587455 | Pembrolizumab and Palliative Radiotherapy in Lung | ||
| NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer | ||
| NCT01726374 | Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours | ||
| NCT01993979 | A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) | ||
| NCT00077090 | Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer | ||
| NCT00578240 | Molecular Studies and Clinical Correlations in Human Prostatic Disease | ||
| NCT05990192 | SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy | ||
| NCT01216800 | Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors | ||
| NCT02375204 | Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients with Relapsed or Refractory Germ Cell Tumors | ||
| NCT05840549 | A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement | ||
| NCT01337401 | A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) | ||
| NCT01332968 | A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) | ||
| NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | ||
| NCT07498829 | Population Based Germline Testing for Early Detection and Prevention of Cancer | ||
| NCT03574454 | Machine Learning in Myeloma Response | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations | ||
| NCT00140582 | Primary Rituximab and Maintenance | ||
| NCT02126800 | Rapid Medical Donation Programme for Breast Cancer | ||
| NCT03621332 | HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy. | ||
| NCT03182634 | The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial | ||
| NCT00107497 | Radiation Therapy in Treating Women With Localized Breast Cancer | ||
| NCT06423976 | Microbiome Molecular Charaterisation | ||
| NCT05533190 | Clinical Investigation of Wysa | ||
| NCT02388308 | Evaluation of Clarity Ultrasound Guidance for Prostate Therapy | ||
| NCT02380027 | PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? | ||
| NCT02973828 | PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy | ||
| NCT05810467 | The Active Surveillance Study | ||
| NCT07391215 | 5G-PEARL: Paxalisib in Malignant Brain Tumours | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab |
